Catheter Precision, Inc. Common Stock VTAK 深 沪
已收盘 08-01 16:00:00 美东时间
0.173
+0.018
+11.25%
华盛通- 最 高0.1749
- 今 开0.1589
- 成交量 126.96万股
- 最 低 0.156
- 昨 收 0.1555
- 总市值 217.87万
- 52周最高 2.49
- 市盈率 静 --
- 换手率 0.01%
- 52周最低 0.151
- 委 比 0.00%
- 总股本 1259.39万
- 历史最高 275000.00
- 量 比 0.85
- 振 幅 12.15%
- 历史最低 0.151
- 每 手 1
- 风险率 1.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Catheter Precision Approves Reverse Stock Split Plan
Catheter Precision ( ($VTAK) ) has provided an announcement. On July 25, 2025, ...
07-29 04:52
Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform
Catheter Precision and Chelak iECG announce their joint venture, Kardionav, to develop advanced AI-based technology for improving ventricular tachycardia ablation. Kardionav will combine AI research with VIVO technology to enhance precision, shorten procedures, and improve patient outcomes. VTAK and Chelak iECG will contribute IP and expertise, with VTAK holding 56%, Chelak iECG 33%, and management 10% ownership. Dr. Jie Cheng, a leading cardiac ...
06-30 12:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Prenetics Global (NASDAQ:PRE) shares moved upwards by 17.8% to $9.45 d...
06-13 20:11
Catheter Precision’s LockeT Sales Surge in Q2 2025
Catheter Precision ( ($VTAK) ) has provided an update. Catheter Precision annou...
06-13 18:45
Catheter Precision Addresses Increased Trading Activity, Reaffirms Strategic Plans
Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common
06-13 02:17
Catheter Precision, Inc. Comments on Recent Market Activity
Catheter Precision, Inc. issued a press release addressing recent increased trading activity in its common stock, noting it is unaware of any specific information related to the activity. The company continues to pursue its strategic plans, including efforts to secure financing to meet liquidity needs.
06-12 18:14
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
Catheter Precision Inc. announced that Q2 2025 LockeT sales are on track to be the highest to date, with a 200% increase compared to Q2 2024. The company has several U.S. hospitals set to place over $100,000 in orders by year-end. LockeT received CE Mark approval, enabling European sales, and Catheter Precision has secured a new distributor in Italy and anticipates additional partners in Spain, Portugal, and the U.K. CEO David Jenkins highlighted...
06-12 11:00
Catheter Precision Stock (VTAK) Rockets 170% on a Delayed Investor Reaction
Catheter Precision stock rocketed higher on Wednesday as investors reacted to i...
06-12 07:44
Why Stitch Fix Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Stitch Fix, Inc. (NASDAQ:SFIX) rose sharply in today's pre-market tra...
06-11 18:23
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital
<p>Catheter Precision Inc., a US-based medical device company, has received its first purchase order for the VIVO product from Sahlgrenska University Hospital, the largest hospital in Sweden. The hospital, which performs many ventricular ablation procedures annually, will use the non-invasive 3D imaging system to streamline workflows and reduce procedure time. This collaboration is expected to aid in training new physicians and expand future sale...
06-09 12:30
